Avecho Biotechnology: Avecho and Sandoz enter exclusive license and development agreement to commercialise CBD for insomnia in Australia
Highlights: Avecho and Sandoz sign an exclusive ten-year development and license agreement ("Agreement") for Avecho's pharmaceutical cannabidiol capsule for insomnia in AustraliaAvecho ...
Avecho and Sandoz enter exclusive license and development agreement to commercialise CBD for insomnia in Australia
Avecho Biotechnology Limited (ASX: AVE) ("Avecho" or the "Company") today announced it has signed an exclusive ten-year development and licensing agreement with Sandoz Group AG ("Sandoz") for the ...
capitalbrief20h
Small-cap ASX biotech Avecho strikes Sandoz deal for CBD insomnia treatment
An Australian biotech minnow wants to become the first company globally to register an over-the-counter cannabidiol product ...